ALZHEON, INC.
New Filing
CIK: 0001582636·Biotechnology·DELAWARE·Filed: Sep 10, 2026
Total Offering
$499,999,999
Amount Sold
$78,797,184
Investors
3
First Sale
Aug 26, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Martin Tolar, M.D., Ph.D. | |
| Christopher Noel Dunn | |
| Neil W. Flanzraich | |
| Jordan Heller | |
| Diane K. Jorkasky, M.D. | |
| Gino Santini | |
| Muneer Satter | |
| Kenneth Mace | |
| Susan Abushakra, M.D. | |
| John Hey, Ph.D. | |
| Aidan Power, MRCPsych | |
| Adem Albayrak |
Company
SEC Filing
0001582636-26-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free